AFM
FCSC

Anson Funds Management’s Fibrocell Science Inc. FCSC Stock Holding History

Anson Funds Management’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-89,627
Closed -$287K – 64
2017
Q4 		$287K Buy
+89,627
New +$783K 0.19% 46

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Anson Funds Management's FCSC Position: Q1 2018 in Review

Anson Funds Management sold out of Fibrocell Science Inc. (FCSC) in Q1 2018, closing a stake of 89,627 shares — an estimated $287K sold.

Anson Funds Management first reported a position in FCSC in Q4 2017 and held it in 1 quarter. The position peaked at $287K in Q4 2017. 30 funds tracked by Wall St. Rank hold FCSC as of Q1 2018.

  • Anson Funds Management reported no remaining Fibrocell Science Inc. position as of Q1 2018 after selling out during the quarter.
  • Anson Funds Management sold 89,627 Fibrocell Science Inc. shares in Q1 2018, an estimated $287K.
  • Anson Funds Management first reported a position in Fibrocell Science Inc. in Q4 2017 and held it in 1 quarter.
  • Anson Funds Management's Fibrocell Science Inc. position peaked at $287K in Q4 2017.
  • 30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2018.

Based on Anson Funds Management's 13F filing for Q1 2018, filed 15 May 2018.